GO:0005654 | nucleoplasm | 4.79e-07 | 4.67e-03 | 2.841 | 9 | 55 | 876 |
GO:0016363 | nuclear matrix | 2.72e-06 | 2.66e-02 | 5.256 | 4 | 7 | 73 |
GO:0010467 | gene expression | 3.49e-06 | 3.41e-02 | 3.190 | 7 | 31 | 535 |
GO:0000398 | mRNA splicing, via spliceosome | 2.55e-05 | 2.49e-01 | 4.446 | 4 | 8 | 128 |
GO:0000812 | Swr1 complex | 3.99e-05 | 3.90e-01 | 7.639 | 2 | 2 | 7 |
GO:0031011 | Ino80 complex | 5.32e-05 | 5.19e-01 | 7.446 | 2 | 2 | 8 |
GO:0008380 | RNA splicing | 6.89e-05 | 6.73e-01 | 4.080 | 4 | 7 | 165 |
GO:0005634 | nucleus | 7.88e-05 | 7.69e-01 | 1.367 | 12 | 67 | 3246 |
GO:0016020 | membrane | 8.03e-05 | 7.84e-01 | 2.209 | 8 | 38 | 1207 |
GO:0071013 | catalytic step 2 spliceosome | 8.04e-05 | 7.85e-01 | 5.100 | 3 | 5 | 61 |
GO:0005730 | nucleolus | 8.53e-05 | 8.33e-01 | 2.197 | 8 | 41 | 1217 |
GO:0043968 | histone H2A acetylation | 8.53e-05 | 8.33e-01 | 7.124 | 2 | 2 | 10 |
GO:0070062 | extracellular vesicular exosome | 9.32e-05 | 9.10e-01 | 1.936 | 9 | 43 | 1641 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.25e-04 | 1.00e+00 | 6.861 | 2 | 3 | 12 |
GO:0005525 | GTP binding | 1.37e-04 | 1.00e+00 | 3.824 | 4 | 5 | 197 |
GO:0005839 | proteasome core complex | 2.26e-04 | 1.00e+00 | 6.446 | 2 | 9 | 16 |
GO:0004298 | threonine-type endopeptidase activity | 2.56e-04 | 1.00e+00 | 6.359 | 2 | 9 | 17 |
GO:0003678 | DNA helicase activity | 2.88e-04 | 1.00e+00 | 6.276 | 2 | 3 | 18 |
GO:0071339 | MLL1 complex | 2.88e-04 | 1.00e+00 | 6.276 | 2 | 2 | 18 |
GO:0043967 | histone H4 acetylation | 4.34e-04 | 1.00e+00 | 5.987 | 2 | 2 | 22 |
GO:0003924 | GTPase activity | 5.82e-04 | 1.00e+00 | 4.136 | 3 | 3 | 119 |
GO:0006184 | GTP catabolic process | 7.54e-04 | 1.00e+00 | 4.009 | 3 | 3 | 130 |
GO:0015030 | Cajal body | 9.24e-04 | 1.00e+00 | 5.446 | 2 | 2 | 32 |
GO:0005515 | protein binding | 1.09e-03 | 1.00e+00 | 1.021 | 12 | 76 | 4124 |
GO:0040008 | regulation of growth | 1.24e-03 | 1.00e+00 | 5.237 | 2 | 2 | 37 |
GO:0005829 | cytosol | 1.30e-03 | 1.00e+00 | 1.643 | 8 | 58 | 1787 |
GO:0032508 | DNA duplex unwinding | 1.30e-03 | 1.00e+00 | 5.198 | 2 | 5 | 38 |
GO:1990259 | histone-glutamine methyltransferase activity | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0004756 | selenide, water dikinase activity | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.52e-03 | 1.00e+00 | 5.088 | 2 | 16 | 41 |
GO:0016071 | mRNA metabolic process | 1.64e-03 | 1.00e+00 | 3.622 | 3 | 21 | 170 |
GO:0000502 | proteasome complex | 1.99e-03 | 1.00e+00 | 4.891 | 2 | 17 | 47 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.16e-03 | 1.00e+00 | 4.831 | 2 | 3 | 49 |
GO:0016070 | RNA metabolic process | 2.19e-03 | 1.00e+00 | 3.476 | 3 | 21 | 188 |
GO:0006310 | DNA recombination | 2.25e-03 | 1.00e+00 | 4.802 | 2 | 6 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.43e-03 | 1.00e+00 | 4.746 | 2 | 17 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.52e-03 | 1.00e+00 | 4.718 | 2 | 17 | 53 |
GO:0016032 | viral process | 2.57e-03 | 1.00e+00 | 2.705 | 4 | 32 | 428 |
GO:0005681 | spliceosomal complex | 2.71e-03 | 1.00e+00 | 4.665 | 2 | 2 | 55 |
GO:0006281 | DNA repair | 2.72e-03 | 1.00e+00 | 3.366 | 3 | 19 | 203 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.81e-03 | 1.00e+00 | 4.639 | 2 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.91e-03 | 1.00e+00 | 4.613 | 2 | 16 | 57 |
GO:0043234 | protein complex | 3.00e-03 | 1.00e+00 | 3.317 | 3 | 8 | 210 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.22e-03 | 1.00e+00 | 4.539 | 2 | 17 | 60 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.33e-03 | 1.00e+00 | 4.515 | 2 | 16 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.77e-03 | 1.00e+00 | 4.424 | 2 | 17 | 65 |
GO:0044822 | poly(A) RNA binding | 3.88e-03 | 1.00e+00 | 2.126 | 5 | 25 | 799 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0001652 | granular component | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0031428 | box C/D snoRNP complex | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0006325 | chromatin organization | 4.36e-03 | 1.00e+00 | 4.317 | 2 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.36e-03 | 1.00e+00 | 4.317 | 2 | 16 | 70 |
GO:0003723 | RNA binding | 4.73e-03 | 1.00e+00 | 3.083 | 3 | 11 | 247 |
GO:0001649 | osteoblast differentiation | 4.86e-03 | 1.00e+00 | 4.237 | 2 | 2 | 74 |
GO:0051414 | response to cortisol | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0030529 | ribonucleoprotein complex | 5.94e-03 | 1.00e+00 | 4.088 | 2 | 4 | 82 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0014075 | response to amine | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0000209 | protein polyubiquitination | 7.42e-03 | 1.00e+00 | 3.922 | 2 | 16 | 92 |
GO:0001055 | RNA polymerase II activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 6 |
GO:0016887 | ATPase activity | 8.72e-03 | 1.00e+00 | 3.802 | 2 | 6 | 100 |
GO:0000278 | mitotic cell cycle | 9.21e-03 | 1.00e+00 | 2.736 | 3 | 35 | 314 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.58e-03 | 1.00e+00 | 3.732 | 2 | 18 | 105 |
GO:0075733 | intracellular transport of virus | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 7 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 7 |
GO:0042981 | regulation of apoptotic process | 1.08e-02 | 1.00e+00 | 3.639 | 2 | 18 | 112 |
GO:0031122 | cytoplasmic microtubule organization | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 2 | 8 |
GO:0042802 | identical protein binding | 1.28e-02 | 1.00e+00 | 2.563 | 3 | 7 | 354 |
GO:0016607 | nuclear speck | 1.28e-02 | 1.00e+00 | 3.515 | 2 | 3 | 122 |
GO:0008266 | poly(U) RNA binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 9 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.34e-02 | 1.00e+00 | 3.480 | 2 | 24 | 125 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 10 |
GO:0007020 | microtubule nucleation | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 1 | 11 |
GO:0071392 | cellular response to estradiol stimulus | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 13 |
GO:0060749 | mammary gland alveolus development | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 2 | 14 |
GO:0010243 | response to organonitrogen compound | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 1 | 14 |
GO:0006259 | DNA metabolic process | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 2 | 14 |
GO:0035145 | exon-exon junction complex | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 15 |
GO:0007067 | mitotic nuclear division | 2.26e-02 | 1.00e+00 | 3.080 | 2 | 8 | 165 |
GO:0005719 | nuclear euchromatin | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 16 |
GO:0006206 | pyrimidine nucleobase metabolic process | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 17 |
GO:0007052 | mitotic spindle organization | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 17 |
GO:0006611 | protein export from nucleus | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 18 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 18 |
GO:0033574 | response to testosterone | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 18 |
GO:0000166 | nucleotide binding | 2.55e-02 | 1.00e+00 | 2.987 | 2 | 6 | 176 |
GO:0000794 | condensed nuclear chromosome | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 3 | 18 |
GO:0044281 | small molecule metabolic process | 2.75e-02 | 1.00e+00 | 1.725 | 4 | 32 | 844 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 20 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 1 | 21 |
GO:0017144 | drug metabolic process | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 1 | 21 |
GO:0030331 | estrogen receptor binding | 3.11e-02 | 1.00e+00 | 4.987 | 1 | 1 | 22 |
GO:0007286 | spermatid development | 3.25e-02 | 1.00e+00 | 4.922 | 1 | 1 | 23 |
GO:0005524 | ATP binding | 3.29e-02 | 1.00e+00 | 1.645 | 4 | 23 | 892 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 25 |
GO:0008033 | tRNA processing | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 1 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.80e-02 | 1.00e+00 | 4.691 | 1 | 2 | 27 |
GO:0034644 | cellular response to UV | 3.94e-02 | 1.00e+00 | 4.639 | 1 | 2 | 28 |
GO:0018107 | peptidyl-threonine phosphorylation | 4.08e-02 | 1.00e+00 | 4.588 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.08e-02 | 1.00e+00 | 4.588 | 1 | 2 | 29 |
GO:0050681 | androgen receptor binding | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 30 |
GO:0043195 | terminal bouton | 4.36e-02 | 1.00e+00 | 4.492 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 4.36e-02 | 1.00e+00 | 4.492 | 1 | 1 | 31 |
GO:0007595 | lactation | 4.49e-02 | 1.00e+00 | 4.446 | 1 | 2 | 32 |
GO:0019003 | GDP binding | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 1 | 34 |
GO:0014070 | response to organic cyclic compound | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 1 | 34 |
GO:0032092 | positive regulation of protein binding | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 2 | 35 |
GO:0030521 | androgen receptor signaling pathway | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 2 | 35 |
GO:0031124 | mRNA 3'-end processing | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 2 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 2 | 36 |
GO:0035690 | cellular response to drug | 5.32e-02 | 1.00e+00 | 4.198 | 1 | 2 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 5.32e-02 | 1.00e+00 | 4.198 | 1 | 2 | 38 |
GO:0006417 | regulation of translation | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 1 | 39 |
GO:0005737 | cytoplasm | 5.58e-02 | 1.00e+00 | 0.891 | 7 | 50 | 2633 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 6 | 40 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 2 | 40 |
GO:0042995 | cell projection | 5.72e-02 | 1.00e+00 | 4.088 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 5.72e-02 | 1.00e+00 | 4.088 | 1 | 9 | 41 |
GO:0031100 | organ regeneration | 6.13e-02 | 1.00e+00 | 3.987 | 1 | 2 | 44 |
GO:0006406 | mRNA export from nucleus | 6.13e-02 | 1.00e+00 | 3.987 | 1 | 1 | 44 |
GO:0032481 | positive regulation of type I interferon production | 6.67e-02 | 1.00e+00 | 3.861 | 1 | 5 | 48 |
GO:0006334 | nucleosome assembly | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 4 | 51 |
GO:0005643 | nuclear pore | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 2 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 5 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.21e-02 | 1.00e+00 | 3.746 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 7.34e-02 | 1.00e+00 | 3.718 | 1 | 9 | 53 |
GO:0043066 | negative regulation of apoptotic process | 7.60e-02 | 1.00e+00 | 2.115 | 2 | 20 | 322 |
GO:0006338 | chromatin remodeling | 7.61e-02 | 1.00e+00 | 3.665 | 1 | 2 | 55 |
GO:0003729 | mRNA binding | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 2 | 57 |
GO:0000785 | chromatin | 8.14e-02 | 1.00e+00 | 3.563 | 1 | 5 | 59 |
GO:0016310 | phosphorylation | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 1 | 60 |
GO:0006366 | transcription from RNA polymerase II promoter | 8.39e-02 | 1.00e+00 | 2.032 | 2 | 6 | 341 |
GO:0006464 | cellular protein modification process | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 61 |
GO:0007565 | female pregnancy | 8.80e-02 | 1.00e+00 | 3.446 | 1 | 2 | 64 |
GO:0042470 | melanosome | 8.80e-02 | 1.00e+00 | 3.446 | 1 | 2 | 64 |
GO:0006364 | rRNA processing | 9.19e-02 | 1.00e+00 | 3.380 | 1 | 4 | 67 |
GO:0005200 | structural constituent of cytoskeleton | 9.33e-02 | 1.00e+00 | 3.359 | 1 | 2 | 68 |
GO:0051082 | unfolded protein binding | 9.59e-02 | 1.00e+00 | 3.317 | 1 | 4 | 70 |
GO:0001889 | liver development | 9.72e-02 | 1.00e+00 | 3.296 | 1 | 1 | 71 |
GO:0005815 | microtubule organizing center | 1.05e-01 | 1.00e+00 | 3.179 | 1 | 1 | 77 |
GO:0019058 | viral life cycle | 1.06e-01 | 1.00e+00 | 3.161 | 1 | 3 | 78 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.14e-01 | 1.00e+00 | 3.054 | 1 | 3 | 84 |
GO:0006915 | apoptotic process | 1.15e-01 | 1.00e+00 | 1.763 | 2 | 21 | 411 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.31e-01 | 1.00e+00 | 2.846 | 1 | 5 | 97 |
GO:0006457 | protein folding | 1.31e-01 | 1.00e+00 | 2.846 | 1 | 4 | 97 |
GO:0007507 | heart development | 1.42e-01 | 1.00e+00 | 2.718 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 1.42e-01 | 1.00e+00 | 2.718 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 1.46e-01 | 1.00e+00 | 2.678 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 1.47e-01 | 1.00e+00 | 2.665 | 1 | 2 | 110 |
GO:0004672 | protein kinase activity | 1.65e-01 | 1.00e+00 | 2.480 | 1 | 2 | 125 |
GO:0031965 | nuclear membrane | 1.71e-01 | 1.00e+00 | 2.424 | 1 | 3 | 130 |
GO:0019904 | protein domain specific binding | 1.71e-01 | 1.00e+00 | 2.424 | 1 | 2 | 130 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.86e-01 | 1.00e+00 | 2.296 | 1 | 2 | 142 |
GO:0005622 | intracellular | 1.89e-01 | 1.00e+00 | 2.266 | 1 | 1 | 145 |
GO:0006351 | transcription, DNA-templated | 1.94e-01 | 1.00e+00 | 0.960 | 3 | 9 | 1076 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.08e-01 | 1.00e+00 | 2.115 | 1 | 4 | 161 |
GO:0007283 | spermatogenesis | 2.16e-01 | 1.00e+00 | 2.054 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 2.19e-01 | 1.00e+00 | 2.028 | 1 | 3 | 171 |
GO:0007264 | small GTPase mediated signal transduction | 2.23e-01 | 1.00e+00 | 2.003 | 1 | 1 | 174 |
GO:0003713 | transcription coactivator activity | 2.34e-01 | 1.00e+00 | 1.922 | 1 | 5 | 184 |
GO:0005743 | mitochondrial inner membrane | 2.48e-01 | 1.00e+00 | 1.824 | 1 | 3 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.55e-01 | 1.00e+00 | 1.781 | 1 | 1 | 203 |
GO:0019899 | enzyme binding | 2.63e-01 | 1.00e+00 | 1.732 | 1 | 4 | 210 |
GO:0005813 | centrosome | 2.70e-01 | 1.00e+00 | 1.684 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 2.71e-01 | 1.00e+00 | 1.678 | 1 | 7 | 218 |
GO:0006200 | ATP catabolic process | 2.72e-01 | 1.00e+00 | 1.671 | 1 | 8 | 219 |
GO:0003682 | chromatin binding | 3.07e-01 | 1.00e+00 | 1.469 | 1 | 6 | 252 |
GO:0046982 | protein heterodimerization activity | 3.20e-01 | 1.00e+00 | 1.396 | 1 | 5 | 265 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.70e-01 | 1.00e+00 | 1.138 | 1 | 7 | 317 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.24e-01 | 1.00e+00 | 0.888 | 1 | 10 | 377 |
GO:0005794 | Golgi apparatus | 4.56e-01 | 1.00e+00 | 0.749 | 1 | 5 | 415 |
GO:0042803 | protein homodimerization activity | 4.66e-01 | 1.00e+00 | 0.705 | 1 | 5 | 428 |
GO:0045087 | innate immune response | 4.85e-01 | 1.00e+00 | 0.626 | 1 | 7 | 452 |
GO:0007165 | signal transduction | 6.00e-01 | 1.00e+00 | 0.175 | 1 | 5 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.15e-01 | 1.00e+00 | 0.115 | 1 | 8 | 644 |
GO:0005739 | mitochondrion | 6.24e-01 | 1.00e+00 | 0.082 | 1 | 11 | 659 |
GO:0008270 | zinc ion binding | 6.62e-01 | 1.00e+00 | -0.060 | 1 | 7 | 727 |
GO:0003677 | DNA binding | 7.60e-01 | 1.00e+00 | -0.441 | 1 | 18 | 947 |
GO:0005886 | plasma membrane | 9.41e-01 | 1.00e+00 | -1.355 | 1 | 11 | 1784 |